Warning: Avoid These Two Stocks in 2016
In short, they appear to have more potential downside than upside at current levels…
Read MoreAuthor: Bret Jensen, Biotech Gems
These Stocks Should Outperform in 2016
Posted by Bret Jensen, Biotech Gems | Dec 1, 2015
One offers a nice combination of growth, value and income…
Read MoreThese Two Undervalued Stocks Are Likely Takeover Targets
Posted by Bret Jensen, Biotech Gems | Nov 25, 2015
I like both as standalone entities, but it makes sense that at least one of them gets bought out at a significant premium in 2016…
Read MoreThese 3 Growth Stocks Look Attractive Right Now
Posted by Bret Jensen, Biotech Gems | Nov 22, 2015
They’re large-caps with cheap valuations, decent prospects, solid balance sheets, and generous dividend yields…
Read MoreI Still Think This Stock Has Solid Upside Potential
Posted by Bret Jensen, Biotech Gems | Nov 19, 2015
I like its risk/reward profile at current levels…
Read More